ROIV — ROIVANT SCIENCES

Ownership history in IFG Advisory, LLC  ·  4 quarters on record

This page tracks every 13F SEC filing in which IFG Advisory, LLC reported a position in ROIVANT SCIENCES (ROIV). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.02% (2025 Q3)
Avg. % of fund
0.02%
First filed
2024 Q3
Last filed
2025 Q3
Quarters held
4
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 29,869 +7,269 +32.2% 0.02% $452K $15.13
2025 Q2 REDUCED 22,600 -660 -2.8% 0.01% $255K $11.27
2024 Q4 ADDED 23,260 +3,055 +15.1% 0.02% $275K $11.83
2024 Q3 INITIATED 20,205 — — 0.01% $233K $11.54
% of Fund (quarterly)    ROIV price (monthly, adj. close)

Other funds also holding ROIV

As of 2025 Q4 — sorted by position size

QVT Financial LP 3Y 7Y 49.1% Patient Square Capital LP 3Y 37.93% Whitefort Capital Management, LP 3Y 11.76% ADAR1 Capital Management, LLC 5.39% BlackBarn Capital Partners LP 4.4% Two Seas Capital LP 3Y 4.38% PENN DAVIS MCFARLAND INC 3Y 7Y 3.86% STEMPOINT CAPITAL LP 3.6% SB INVESTMENT ADVISERS (UK) LTD 3Y 7Y 3.56% PERCEPTIVE ADVISORS LLC 3Y 7Y 3.09%
← Back to IFG Advisory, LLC Holdings